Next Capital Management’s DexCom DXCM Stock Holding History

Next Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-544	Closed	-$20K	–	405
2019 Q2	$20K	Buy	+544	New	+$17.1K	0.01%	307

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Next Capital Management's DXCM Position: Q3 2019 in Review

Next Capital Management sold out of DexCom (DXCM) in Q3 2019, closing a stake of 544 shares — an estimated $20K sold.

Next Capital Management first reported a position in DXCM in Q2 2019 and held it in 1 quarter. The position peaked at $20K in Q2 2019. 424 funds tracked by Wall St. Rank hold DXCM as of Q3 2019.

Next Capital Management reported no remaining DexCom position as of Q3 2019 after selling out during the quarter.
Next Capital Management sold 544 DexCom shares in Q3 2019, an estimated $20K.
Next Capital Management first reported a position in DexCom in Q2 2019 and held it in 1 quarter.
Next Capital Management's DexCom position peaked at $20K in Q2 2019.
424 funds tracked by Wall St. Rank held DexCom as of Q3 2019.

Based on Next Capital Management's 13F filing for Q3 2019, filed 12 Nov 2019.